NCT05183984 2026-04-13
NIRVANA-1
ARCAGY/ GINECO GROUP
Phase 2 Recruiting
Clinical Trials
61 trialsNCT02122185 2026-03-27
Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
University of Chicago
Phase 2 Completed
NCT05143970 2026-03-20
CHANCES
Institut Paoli-Calmettes
Phase 1 Recruiting
NCT03785574 2026-03-16
Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule
Women's Hospital School Of Medicine Zhejiang University
Phase NA Recruiting
NCT05763199 2026-03-12
Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy
University of California, Davis
Phase 2 Active not recruiting
NCT04575935 2026-03-05
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
M.D. Anderson Cancer Center
Phase 3 Recruiting
NCT04857528 2026-03-04
Detecting HPV DNA in Anal and Cervical Cancers
University of Chicago
Recruiting
NCT07033819 2026-02-27
Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
NCT03943173 2026-02-25
Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT07340489 2026-01-14
Serplulimab for Locally Advanced Cervical Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting
NCT06727617 2026-01-06
Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting
NCT06529809 2025-12-24
Accelerated Brachytherapy Forward Chemo Radiation Therapy (ABC-RT) for Locally-advanced Cervical Cancer
Washington University School of Medicine
Phase 1/2 Recruiting
NCT07167160 2025-12-18
Chemo-immunotherapy for Cervical Cancer Stage IIICp Trial
Women's Hospital School Of Medicine Zhejiang University
Phase 2 Recruiting
NCT07286240 2025-12-16
QL1706 Combined With Chemotherapy and Anlotinib for the Treatment of Recurrent Ovarian Cancer
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 2 Recruiting
NCT07244965 2025-11-24
Neoadjuvant Ivonescimab Plus Chemotherapy Followed by Concurrent Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer
Women's Hospital School Of Medicine Zhejiang University
Phase 2 Not yet recruiting
NCT06877572 2025-10-27
ECS Weight
University of Kansas Medical Center
Recruiting
NCT02635360 2025-07-03
Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer
University of Virginia
Phase 2 Completed
NCT06990503 2025-05-25
SHR - A1811 Versus Chemotherapy for Platinum-resistant Recurrent Epithelial Ovarian Cancer
Tongji Hospital
Phase 3 Not yet recruiting
NCT06945601 2025-04-25
FECONDE
IRCCS San Raffaele
Not yet recruiting
NCT05857631 2025-04-15
PARCERII
Tata Memorial Centre
Phase NA Recruiting
NCT05704621 2025-03-06
SOCCER-P
Korea University Guro Hospital
Phase 2 Recruiting
NCT06353061 2025-01-14
Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer
Peking Union Medical College Hospital
Phase 2 Recruiting
NCT03314740 2025-01-10
BAROCCO
Mario Negri Institute for Pharmacological Research
Phase 2 Completed
NCT05255653 2024-11-29
RAINBO
Leiden University Medical Center
Phase 2/3 Recruiting
NCT05684731 2024-08-13
K19017-004
Tongji Hospital
Phase 1 Recruiting
NCT03539406 2024-08-09
INTRO
Radboud University Medical Center
Phase 1 Completed
NCT06535334 2024-08-02
Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
Far Eastern Memorial Hospital
Not yet recruiting
NCT03755739 2024-06-25
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
Phase 2/3 Recruiting
NCT03757858 2024-02-07
Hyperthermia Combined With Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases
Capital Medical University
Phase 1/2 Completed
NCT05364905 2023-09-06
ENDOVIE
ARCAGY/ GINECO GROUP
Completed
NCT05076942 2023-08-01
GROINSS-VIII
University Medical Center Groningen
Phase 2 Recruiting
NCT05410938 2023-07-10
Intraperitoneal Chemotherapy Versus Triweekly Chemotherapy
Far Eastern Memorial Hospital
Completed
NCT04201561 2023-06-26
SELENIUM
Seoul National University Hospital
Phase 3 Unknown
NCT05541146 2023-03-23
Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis
Instituto do Cancer do Estado de São Paulo
Phase 2 Unknown
NCT05733806 2023-02-23
MITO9B
National Cancer Institute, Naples
Recruiting
NCT05524389 2022-11-23
Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions
Peking Union Medical College Hospital
Phase 3 Not yet recruiting
NCT05607329 2022-11-07
Secondary Cytoreduction Followed by Chemotherapy Versus Chemotherapy Alone in Relapsed Ovarian Cancer After PARPi Maintenance Treatment: a Multicentre, Open-label, Randomised, Phase 3 Trial
Women's Hospital School Of Medicine Zhejiang University
Phase NA Recruiting
NCT05437692 2022-10-12
Zimberelimab Combined With Concurrent Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
Shanghai Zhongshan Hospital
Phase 2 Unknown
NCT01809379 2022-07-08
Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian Cancer
Ruhr University of Bochum
Phase 2 Completed
NCT05422183 2022-06-16
Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer
Zhongda Hospital
Phase 2 Unknown
NCT04756713 2022-05-27
ReCure
Brigham and Women's Hospital
Phase 3 Unknown
NCT02067052 2022-04-15
New Strategy for the Treatment of Vulvar Cancer
Instituto do Cancer do Estado de São Paulo
Unknown
NCT04795596 2022-04-15
Secondary Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancers
Menoufia University
Phase 2/3 Withdrawn
NCT04188847 2022-03-15
First-line Chemotherapy for Recurrent Cervical Cancer
Peking Union Medical College Hospital
Phase 2 Completed
NCT03955367 2022-02-23
Pelvic RT Versus Prophylactic Extended-field RT in Patients With Cervical Cancer
Peking Union Medical College Hospital
Phase 3 Unknown
NCT05170594 2021-12-28
A Study of Bevacizumab Combined With Fluzoparib/Chemotherapy or Fluzoparib in the Treatment of Ovarian Cancer
The Second Affiliated Hospital of Shandong First Medical University
Phase 2 Unknown
NCT04620954 2021-12-01
ORION-02
National Cancer Centre, Singapore
Phase 1/2 Unknown
NCT05059782 2021-09-28
Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer
Xi'an Jiaotong University
Phase NA Unknown
NCT03308604 2021-07-07
NANOCOL
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1 Unknown
NCT04747717 2021-02-11
Efficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian Cancer
N.N. Petrov National Medical Research Center of Oncology
Phase NA Unknown